Evaluation of the efficacy and safety of tolcapone (Tasmar) in Parkinson's disease patients with a stable response to levodopa

被引：0
|
作者：
Waters, CH
Kurth, MC
Shulman, L
Bailey, P
Shale, H
Dorflinger, E
Yoo, K
Shimoun, G
Pedder, S
机构：
来源：
NEUROLOGY | 1996年 / 46卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：4006 / 4006
页数：1
相关论文
共 50 条
  • [1] Tolcapone in stable Parkinson's disease: Efficacy and safety of long-term treatment
    Waters, CH
    Kurth, M
    Bailey, P
    Shulman, LM
    LeWitt, P
    Dorflinger, E
    Deptula, D
    Pedder, S
    [J]. NEUROLOGY, 1997, 49 (03) : 665 - 671
  • [2] The beneficial effects of tolcapone (Tasmar) on sleep disability in Parkinson's disease patients with motor fluctuations
    Stiasny, K
    Deptula, D
    Dorflinger, E
    [J]. NEUROLOGY, 1998, 50 (04) : A262 - A263
  • [3] Multicenter evaluation of tolcapone (Tasmar) when given together with levodopa to Parkinson disease patients who exhibit end-of dose wearing off
    Dorflinger, EE
    Rajput, A
    Martin, W
    SaintHilaire, MH
    Chernik, D
    Yoo, K
    Shimoun, G
    Pedder, S
    [J]. NEUROLOGY, 1996, 46 (02) : 67001 - 67001
  • [4] Safety and efficacy of tolcapone in Parkinson's disease: systematic review
    Artusi, Carlo Alberto
    Sarro, Lidia
    Imbalzano, Gabriele
    Fabbri, Margherita
    Lopiano, Leonardo
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (06) : 817 - 829
  • [5] Safety and efficacy of tolcapone in Parkinson’s disease: systematic review
    Carlo Alberto Artusi
    Lidia Sarro
    Gabriele Imbalzano
    Margherita Fabbri
    Leonardo Lopiano
    [J]. European Journal of Clinical Pharmacology, 2021, 77 : 817 - 829
  • [6] Population pharmacokinetics of levodopa in patients with Parkinson's disease treated with tolcapone
    Jorga, K
    Banken, L
    Fotteler, B
    Snell, P
    Steimer, JL
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (06) : 610 - 620
  • [7] Psychosocial adjustment and illness impact in Parkinson's disease patients before and after treatment with tolcapone (Tasmar)
    Welsh, MD
    Ved, N
    Waters, CH
    [J]. NEUROLOGY, 1996, 46 (02) : 4129 - 4129
  • [8] Tolcapone (TASMAR®) in the treatment of advanced Parkinson's disease:: Results of a postmarketing surveillance study
    Ebersbach, G.
    [J]. MOVEMENT DISORDERS, 2007, 22 : S244 - S244
  • [9] The efficacy of homemade tolcapone in the treatment of patients with Parkinson's disease
    Zhang, Pei-Lan
    Wang, Yu-Xin
    Chen, Yan
    Zhang, Chen-Hao
    Li, Chen-Hua
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 15 (01) : 127 - 130
  • [10] Vitiligo associated with tolcapone and levodopa in a patient with Parkinson's disease
    Sabaté, M
    Bosch, A
    Pedrós, C
    Figueras, A
    [J]. ANNALS OF PHARMACOTHERAPY, 1999, 33 (11) : 1228 - 1229
12345